Evaluation of standard tyrosinase RT-PCR in melanoma patients by the use of the LightCycler™ system

Clinica Chimica Acta

Volumn 306, Issue 1-2, 2001, Pages 133-138

  Stoitchkov, Konstantin ^a   Letellier, Sabine ^b,c   Garnier, Jean Pierre ^b,c   Toneva, Miglena ^d   Naumova, Elissaveta ^d   Peytcheva, Ekaterina ^a   Tzankov, Nikolai ^e   Bousquet, Bernard ^b,c   Morel, Patrice ^b   Le Bricon, Thierry ^b  

^a National Cancer Hospital   (Bulgaria)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Laboratory of Clinical Immunology   (Bulgaria)

^e MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

LightCycler system; Melanoma; RT PCR; Tyrosinase

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MELANOMA; MELANOMA CELL; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TYROSINE;

EID: 0035078379     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00400-4     Document Type: Article

References (17)

1. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
2. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
3. New prognostic factors in melanoma: mRNA tumor markers
4. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse-transcription PCR
5. Polymerase chain reaction detection of circulating tumor cells
6. Simultaneous analysis of tyrosinase mRNA and markers of tyrosinase activity in the blood of patients with metastatic melanoma
7. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival
8. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression
9. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
10. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
11. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two center study
12. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: A comparison with the whole blood guanidinium isothiocyanate RNA isolation method
13. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: Quality control study using real-time quantitative RT-PCR
14. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood
15. Detection of tyrosinase mRNA in melanoma by reverse transcription PCR and electrochemiluminescence